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Acute Page Kidney (APK) phenomenon is a rare cause of secondary hypertension, mediated by activation of renin-angiotensin-
aldosterone system (RAAS). Timely intervention is of great importance to prevent any end organ damage from hypertension. We
present a unique case of three episodes of APK in the same renal transplant allograft.
1. Case
A 42-year-old female with hypertension (HTN), ESRD,
secondary to IgA nephropathy and a history of deceased
donor renal transplant, presented with acute kidney injury
(AKI). Her AKI was presumed to be prerenal due to ongoing
gastroenteritis. Her S Cr was elevated to 3.3mg/dL (from
baseline of 2–2.2mg/dL) and admission blood pressure (BP)
ranged with 190/100–210/110mmHg. She was on mycophe-
nolic acid 360mg QID, sirolimus 1mg daily, prednisone
5mg daily, and carvedilol 50mg BID. Her renal transplant
ultrasonography (USG) showed normal resistive indices (RI)
with no hydronephrosis. An allograft biopsy was performed
to rule out transplant rejection, as her S Cr continued to
be elevated at 3.3mg/dL even after 72 hours of hydration
and negative GI workup. Her antihypertensive regime was
adjusted with the addition of nifedipine, clonidine, and
minoxidil and her blood pressure ranged within 140–160/80–
95 during 48 hours prior to procedure. On postprocedure
day 1, her blood pressure was again elevated (170–210/90–
110mmHg) and she had a noticeable drop in her hemoglobin
(Hgb) from 10 g/dL to 8.5 g/dL. Her CT scans showed
large subcapsular hematoma. Renal allograft angiography
failed to show any active bleeding, an AV fistula, or any
pseudoaneurysm formation. On postbiopsy day 2, her BP
remained high and the S Cr peaked at 4.2mg/dL prompting
the drainage of subcapsular hematoma and a Jackson-Pratt
(J/P) drain placement for continuous drainage. This resulted
in significant improvement in blood pressure (Figure 1) and
her IV antihypertensives were tapered off within 24 hours
of drainage. Her S Cr improved to 3.1mg/dL and her J/P
drain was removed on day 5. She was soon discharged on
PO antihypertensive regime. Her allograft biopsy showed
moderate fibrosis with no evidence of antibody or cell
mediated rejection or any other acute process.
Unfortunately, sixweeks later shewas readmittedwith severe
anemia (Hgb 6.4 g/dL), AKI (S Cr of 8.3mg/dL), and hyper-
tensive emergency (BP range of 190/90–210/110mmHg). Her
CT scans confirmed recurrence of the subcapsular hematoma.
Again, renal allograft angiography failed to show any active
bleeding or any AV malformations. This time, the hem-
atoma was surgically drained to ensure the bleeding stopped
after drainage. A J/P drainwas again placedwhichwas removed
after 2weeks. She required four sessions of hemodialysis treat-
ments for this episode ofAKI but her renal function stabilized
at discharge with S Cr of 3.1mg/dL and improved BP control
(Figure 1). A repeat USG at discharge showed complete
resolution of hematoma. An overt cause for recurrence of
hematomawas not elucidated by angiography. She was not on
any anticoagulation and her coagulation profile was normal.
She was admitted again seven weeks later, for a large
perinephric seroma with uncontrolled HTN (190/90–
200/110mmHg). The collection was drained emergently with
an immediate and significant improvement in her BP (range
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Figure 1: Data points showing systolic blood pressures (a) and
diastolic blood pressures (b).Different colored arrows showdifferent
hospital admissions. The arrows depict the improvements in blood
pressures after treatment of Acute Page Kidney.
110–130/60–70) (Figure 1). Her renal function remained at
baseline and she had no acute kidney injury. She had nomore
recurrence of Page Kidney phenomenon and her antihyper-
tensive regime is managed successfully as an outpatient.
2. Discussion
The phenomenon of worsening of blood pressure from
compression of the renal parenchyma by either a subcapsular
collection or extrarenal collection causing renal hypoper-
fusion/ischemia and triggering of the renin-angiotensin-
aldosterone system (RAAS) is known as Page Kidney. Dr.
Page first described it in 1939 [1] when he wrapped a canine
kidney with cellophane, causing constrictive perinephritis
leading to compression of the kidney parenchyma and hyper-
tension. Along with HTN, AKI can also be seen, more so in
the setting of a nonfunctioning contralateral native kidney,
a solitary kidney, or a patient with renal allograft. In our
patient, uncontrolled HTN and AKI were both seen.
APK most commonly is associated with perinephric
hematoma. In one case series [2] blunt trauma was reported
as the cause in 44% of patients with APK. In the present
world, where renal biopsies are done extensively, many more
cases of perinephric hematoma causing APK have been
described in the postrenal biopsy setting, both after native
and transplant kidney biopsy. It holds more importance in
the case of transplant kidney as missing the diagnosis and
delayed intervention might lead to graft loss. The incidence
of APK posttransplant kidney biopsy has been reported
around 1% by Chung et al. [3], reported less than 4% by
McCune et al. [2], and more recently reported around 36%
by Dopson et al. [4]. Apart from perinephric hematoma,
authors have suggested APK with seroma or urinoma [2, 5],
with postsurgical lymphocele [6], perinephric tumors [7],
and postextracorporeal shock wave lithotripsy [8]. It has also
been described by spontaneous hematoma in a patient with
polyarteritis nodosa [9]. Our case of multiple recurrences of
APK episodes in the same allograft is the first reported case
of its kind. The first episode of APK was due to subcapsular
bleed after the biopsy. The first recurrence was presumed
to be due to very slow continuous oozing of blood in the
subcapsular space due to platelet dysfunction given patient’s
recent AKI onCKD stage 4 status [10].The second recurrence
of APK was due to perinephric seroma that formed after
open surgical drainage of the hematoma during previous
admission. During the first two episodes of APK, renal
transplant angiography failed to show any active bleeding
source. Our patients’ coagulation profile was normal and was
not on any form of anticoagulation. There was no clinical
suspicion of any formof vasculitis and the biopsy also showed
no active vasculitic process. Chung et al. [3] described it in 4
patients (out of 518 transplant kidney biopsies); all 4 cases pre-
sented with AKI secondary to subcapsular hematoma in the
postbiopsy setting. Acute decompression led to improvement
in AKI in 3 patients whereas 4th patient lost the graft (acute
antibody mediated rejection). Cromie et al. [11] described
Page Kidney following living related renal transplantation
that presentedwith refractory hypertension fromperinephric
hematoma. Successful evacuation by capsulotomy resulted in
improved HTN and normal renal function. Vanwalleghem et
al. [6] presented peritransplant lymphocele as a cause of Page
Kidney. Yussim et al. [12] described successful treatment of
Page Kidney by removal of fibrotic perinephric tissue that
developed as a consequence of surgical treatment of peri-
transplant lymphocele. All such case reports from transplant
literature present good outcomes after primary medical or
surgical management. Our case is unique in the fact that
even after initial appropriatemanagement and stabilization of
first episode of Page Kidney the APK phenomenon recurred
again causing even worse symptoms of HTN and AKI with
hemodialysis requirement temporarily.
The management of APK and treatment need to be
individualized to case-by-case basis and should be guided
by extent of organ damage and severity of presentation. In
cases with HTN emergency, a more aggressive approach
including surgical drainage or arterial embolization [13] may
be required. In kidney transplant patients, aggressive man-
agement is often necessary to ensure viability of the allograft.
In our case, during the first episode, even after 72 hours of
aggressive medical management, subsequent interventional
radiology management was warranted for resistant HTN
and worsening renal function. During second episode even
after immediate open surgical evacuation patient remained
dialysis dependent for 1 week but eventually recovered renal
function. Urgent drainage of perinephric seroma at third
presentation resulted in immediate improvement in BP.
In conclusion, APK is a rare but very serious complication
that can be seen after renal allograft biopsy. New onset of
acute pain over the graft, uncontrolled blood pressure, and
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reduction of Hgb could be the ominous signs. High risk
patients such as patients with coagulopathy and uncontrolled
HTN should be followed up closely after APK episode as
recurrence of hematoma and new perinephric collections
including seroma are possible. Our case report is the first case
of Recurrent Acute Page Kidney phenomenon in the same
allograft and emphasizes the need for close follow-up of such
patients even after initial management.
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